Back to search

France· FR:64848430

ALFUZOSINE EVOLUGEN L.P. 10 mg, comprimé pelliculé à libération prolongée

A alfuzosin product containing chlorhydrate d'alfuzosine, registered in France by EVOLUPHARM, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC G04CA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedALFUZOSINE EVOLUGEN L.P. 10 mg, compr…ATCG04CA01REGISTER NO.FR:64848430PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Alfuzosin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04CA01 (alfuzosin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose

Alfuzosin · ATC G04CA01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfuzosin costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.25 in France to $0.93 in Switzerland — a ×3.7 gap.

  • France: $0.25 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Alfuzosin · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.93
  • ES Spain$0.34
  • IT Italy$0.25
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE D'ALFUZOSINE
Manufacturer
EVOLUPHARM
Country
France (FR)
ATC code
G04CA01
ATC class
Alfuzosin
Defined daily dose
7.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400938631968
    plaquette(s) PVC-Aluminium de 30 comprimé(s)
    EUR 8.76

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

330 interactions on record for alfuzosin.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alfuzosin · interactions on record

330 records

  • 47 severe
  • 182 moderate
  • 3 minor
  • 48 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PapaverinC04AX38severe

50 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alfuzosin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alfuzosin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Alfuzosin Stada
  • Belgium · Alfuzosine Sandoz, Xatral Retard
  • Cyprus · Alfural, Alfuzosin Aurobindo
  • Czechia · Alfuzosin Viatris
  • Germany · Alfuzosin, Alfuzosin 10 1 A Pharma
  • Denmark · Alfuzosin Orion, Alfuzosin Sandoz
  • Estonia · Alfuzosin Teva, Xatral Sr
  • Spain · Alfuzosina Aurovitas, Alfuzosina Stada
  • Finland · Alfuzosin Hydrochlorid Ratiopharm, Alfuzosin Hydrochloride Orion
  • United Kingdom (Northern Ireland) · Alfuzosin Hcl Milpharm, Alfuzosin Hydrochloride Teva Uk
  • Greece · Alcinin, Alfudex
  • Hungary · Alfetim Sr, Alfetim Uno
  • Ireland · Alfu, Xatger
  • Iceland · Alfuzosin Hydrochloride Alvogen
  • Italy · Alfuzosin Ratiopharm, Alfuzosina Aurobindo
  • Lithuania · Xatral Sr
  • Luxembourg · Xatral Uno
  • Latvia · Alfuzosin Teva, Xatral Sr
  • Malta · Zochek
  • Netherlands · Alfuzosine Hcl Aurobindo, Alfuzosine Hcl Cf
  • Poland · Alfabax, Alfurion
  • Portugal · Alfuzosin Teva, Alfuzosina Aurovitas
  • Romania · Xatral Sr
  • Sweden · Alfuzosin Orion, Alfuzosin Rivopharm
  • Slovakia · Alfuzosin Sandoz, Alfuzosin Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb5a60dd-0b51-42f7-9af4-491543f7c1b0
GET /v1/drugs/eb5a60dd-0b51-42f7-9af4-491543f7c1b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64848430",
  "date_amm": "2008-07-09",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE D'ALFUZOSINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about alfuzosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.